Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ResMed Inc. Common Stock
(NY:
RMD
)
210.98
+2.42 (+1.16%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ResMed Inc. Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
19
20
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 25, 2024
Via
Benzinga
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
April 25, 2024
From
ResMed Inc.
Via
GlobeNewswire
How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher
↗
April 18, 2024
ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.
Via
Investor's Business Daily
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
↗
April 17, 2024
The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
Via
The Motley Fool
Why NYSE:RMD qualifies as a good dividend investing stock.
↗
April 08, 2024
Why the dividend investor may take a look at RESMED INC (NYSE:RMD).
Via
Chartmill
Expert Outlook: ResMed Through The Eyes Of 9 Analysts
↗
March 27, 2024
Via
Benzinga
Peering Into ResMed's Recent Short Interest
↗
March 26, 2024
Via
Benzinga
Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
↗
April 17, 2024
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.
Via
Investor's Business Daily
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
↗
April 15, 2024
Via
Benzinga
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
↗
April 08, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER).
Via
Benzinga
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
April 04, 2024
From
ResMed Inc.
Via
GlobeNewswire
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
↗
March 06, 2024
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock.
Via
Chartmill
Uncovering Dividend Opportunities with NYSE:RMD.
↗
February 12, 2024
Why RESMED INC (NYSE:RMD) provides a good dividend, while having solid fundamentals.
Via
Chartmill
Cracking The Code: Understanding Analyst Reviews For ResMed
↗
January 25, 2024
Via
Benzinga
$1000 Invested In ResMed 10 Years Ago Would Be Worth This Much Today
↗
March 28, 2024
Via
Benzinga
ASX : RMD - Resmed Stock Analysis & Elliott Wave Technical Forecast
↗
March 21, 2024
Our Elliott Wave analysis updates the Australian Stock Exchange with Resmed Inc shares. We have identified an Expanded Flat correction pattern, indicating the potential for RMD to continue declining...
Via
Talk Markets
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
March 15, 2024
From
ResMed Inc.
Via
GlobeNewswire
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
March 06, 2024
From
ResMed Inc.
Via
GlobeNewswire
Why ResMed Stock Is Jumping Today
↗
January 25, 2024
The medical device maker beat expectations with its latest quarterly results.
Via
The Motley Fool
Recap: ResMed Q2 Earnings
↗
January 24, 2024
Via
Benzinga
ResMed's Earnings: A Preview
↗
January 23, 2024
Via
Benzinga
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
↗
February 22, 2024
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.
Via
The Motley Fool
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
February 12, 2024
From
ResMed Inc.
Via
GlobeNewswire
MatrixCare Earns Three 2024 Best in KLAS Awards
February 07, 2024
MatrixCare has been named a market leader by KLAS Research for its Home Health EHR in three Categories: Home Health – Independent – Large, Home Health – Independent – Small, and Hospice – Independent
From
MatrixCare
Via
GlobeNewswire
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
↗
February 01, 2024
Via
Benzinga
ResMed Flexes Its Operating Muscle, Sends Shares Flying Above Their 200-Day Line
↗
January 25, 2024
ResMed reported better-than-expected sales and adjusted earnings.
Via
Investor's Business Daily
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
↗
January 25, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
January 24, 2024
From
ResMed Inc.
Via
GlobeNewswire
Earnings Scheduled For January 24, 2024
↗
January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.
Via
Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
↗
January 23, 2024
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation.
Via
InvestorPlace
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
